UBS AG - RAPTOR PHARMACEUTICAL CORP ownership

RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 83 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q3 2014. The put-call ratio across all filers is 1.33 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS AG ownership history of RAPTOR PHARMACEUTICAL CORP
ValueSharesWeighting
Q3 2014$38,000
-24.0%
4,000
-8.0%
0.00%
Q2 2014$50,000
-43.8%
4,350
-50.8%
0.00%
Q1 2014$89,000
+43.5%
8,850
+84.6%
0.00%
Q4 2013$62,000
-6.1%
4,794
+8.4%
0.00%
Q3 2013$66,000
-43.1%
4,422
-64.4%
0.00%
Q2 2013$116,00012,4100.00%
Other shareholders
RAPTOR PHARMACEUTICAL CORP shareholders Q3 2014
NameSharesValueWeighting ↓
Trellus Management Company, LLC 63,500$1,003,0001.13%
Broadfin Capital, LLC 1,319,883$20,841,0001.12%
BAILARD, INC. 160,000$2,526,0000.39%
Birchview Capital, LP 46,000$726,0000.38%
HIGHLAND CAPITAL MANAGEMENT LP 1,182,167$18,666,0000.38%
Rock Springs Capital Management LP 305,000$4,816,0000.35%
SPHERA FUNDS MANAGEMENT LTD. 206,500$3,261,0000.32%
GLOBEFLEX CAPITAL L P 109,771$1,733,0000.32%
GROUP ONE TRADING, L.P. 1,319,766$20,839,0000.29%
Perceptive Advisors 264,204$4,172,0000.25%
View complete list of RAPTOR PHARMACEUTICAL CORP shareholders